ARTICLE | Clinical News

MiRview mets2 regulatory update

December 19, 2011 8:00 AM UTC

The New York State Department of Health approved Rosetta's miRview mets2 test to identify the primary origin of tumor of uncertain or unknown origin. New York is the only state in the U.S. with an ind...